Tuberculosis screening among newly arrived asylum seekers in Denmark
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Tuberculosis screening among newly arrived asylum seekers in Denmark. / Kristensen, Kristina Langholz; Nørredam, Marie; Jensen, Sidse Graff; Seersholm, Niels; Jorgensen, Marie Louise; Exsteen, Banoo Bakir; Huber, Franziska Grundtvig; Munk-Andersen, Ebbe; Lillebaek, Troels; Ravn, Pernille.
I: Infectious Diseases, Bind 54, Nr. 11, 2022.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Tuberculosis screening among newly arrived asylum seekers in Denmark
AU - Kristensen, Kristina Langholz
AU - Nørredam, Marie
AU - Jensen, Sidse Graff
AU - Seersholm, Niels
AU - Jorgensen, Marie Louise
AU - Exsteen, Banoo Bakir
AU - Huber, Franziska Grundtvig
AU - Munk-Andersen, Ebbe
AU - Lillebaek, Troels
AU - Ravn, Pernille
PY - 2022
Y1 - 2022
N2 - Background Tuberculosis (TB) screening programmes among asylum seekers tend to focus on chest radiography (CXR) for early diagnosis, whereas knowledge on sputum examination is limited. We evaluated active TB screening using CXR and sputum culture among asylum seekers arriving in Denmark. In addition, we assessed the coverage of a voluntary health assessment. Methods Between 1 February 2017 and 31 March 2019, all newly arrived asylum seekers in Denmark >= 18 years from TB high-incidence countries or risk groups, who attended a voluntary general health assessment, were offered active TB screening with CXR and spot sputum examination. Sputum samples were examined by culture and smear microscopy. Results Coverage of the general health assessment was 65.1%. Among 1,154 referred for active TB screening, 923 (80.0%) attended. Of these, 854 were screened by CXR and one case of active TB was identified equivalent to a yield of 0.12%. Sputum samples were collected from 758 and one M. tuberculosis culture-positive TB case (also identified by CXR) was identified, equivalent to a yield of 0.13%. No cases were found by sputum culture screening only. In addition, screening found three cases of malignant disease. Conclusion We suggest that TB screening should focus on asylum seekers from TB high-incidence countries. Furthermore, early health assessments should be of high priority to ensure migrant health.
AB - Background Tuberculosis (TB) screening programmes among asylum seekers tend to focus on chest radiography (CXR) for early diagnosis, whereas knowledge on sputum examination is limited. We evaluated active TB screening using CXR and sputum culture among asylum seekers arriving in Denmark. In addition, we assessed the coverage of a voluntary health assessment. Methods Between 1 February 2017 and 31 March 2019, all newly arrived asylum seekers in Denmark >= 18 years from TB high-incidence countries or risk groups, who attended a voluntary general health assessment, were offered active TB screening with CXR and spot sputum examination. Sputum samples were examined by culture and smear microscopy. Results Coverage of the general health assessment was 65.1%. Among 1,154 referred for active TB screening, 923 (80.0%) attended. Of these, 854 were screened by CXR and one case of active TB was identified equivalent to a yield of 0.12%. Sputum samples were collected from 758 and one M. tuberculosis culture-positive TB case (also identified by CXR) was identified, equivalent to a yield of 0.13%. No cases were found by sputum culture screening only. In addition, screening found three cases of malignant disease. Conclusion We suggest that TB screening should focus on asylum seekers from TB high-incidence countries. Furthermore, early health assessments should be of high priority to ensure migrant health.
KW - Asylum seekers
KW - tuberculosis
KW - screening
KW - sputum culture
KW - coverage
KW - LOW-INCIDENCE COUNTRIES
KW - MIGRANTS
KW - ENTRY
KW - SURVEILLANCE
KW - IMMIGRANTS
KW - EUROPE
KW - CARE
U2 - 10.1080/23744235.2022.2106380
DO - 10.1080/23744235.2022.2106380
M3 - Journal article
C2 - 36000199
VL - 54
JO - Infectious Diseases
JF - Infectious Diseases
SN - 2374-4235
IS - 11
ER -
ID: 318184529